Acadia Pharmaceuticals Inc

Connor, Clark & Lunn Investment Management Ltd. ACAD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

580,969

Value ($000)

15,518

Weight

0.0%

2022 Q1 - 2025 Q4 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	15,518	0.0%	580,969	12/31/2025
2025 Q3	11/13/2025	14,263	0.0%	668,363	9/30/2025
2025 Q2	8/7/2025	13,858	0.0%	642,448	6/30/2025
2025 Q1	5/12/2025	9,505	0.0%	572,261	3/31/2025
2024 Q4	2/10/2025	12,583	0.1%	685,716	12/31/2024
2024 Q3	11/8/2024	14,960	0.1%	972,665	9/30/2024
2024 Q2	8/9/2024	20,370	0.1%	1,253,542	6/30/2024
2024 Q1	5/9/2024	15,833	0.1%	856,299	3/31/2024
2023 Q4	2/9/2024	19,643	0.1%	627,384	12/31/2023
2023 Q3	11/13/2023	13,201	0.1%	633,469	9/30/2023
2023 Q2	8/10/2023	12,827	0.1%	535,581	6/30/2023
2023 Q1	5/10/2023	9,376	0.1%	498,178	3/31/2023
2022 Q4	2/10/2023	7,794	0.0%	489,546	12/31/2022
2022 Q3	11/10/2022	8,342	0.1%	509,921	9/30/2022
2022 Q2	8/5/2022	2,135	0.0%	151,516	6/30/2022
2022 Q1	5/12/2022	1,396	0.0%	57,635	3/31/2022